Altogether, miR-320a, -b and -c may serve as diagnostic biomarkers i) to distinguish PCa patients from those with BPH and from healthy controls, ii) to identify PCa patients early and iii) to identify those with a PSA relapse. Here, KLK3 is linked to benign prostatic hyperplasia.